Aberrant N-glycosylation may be a therapeutic target in carriers of a common and highly pleiotropic variant in the manganese transporter ZIP8

$0.00

Want a discount? Become a member by purchasing a membership and you could save up to $0.00!

You must log in or create an account before you can add this item to your cart.

Description

The November Journal Club will feature a talk from HGG Advances author, Joanna Melia, discussing their paper: “Aberrant N-glycosylation may be a therapeutic target in carriers of a common and highly pleiotropic variant in the manganese transporter ZIP8“.